Purpose: To evaluate feasibility, safety, and success of peripheral embolization procedures carried out using anti-reflux microcatheter with N-butyl-cyanoacrylate (NBCA) as an embolic agent. Methods: We retrospectively described 11 patients that suffered from active bleeding in different body districts, who underwent embolization procedure using SeQure microcatheter (Guerbet, France) with NBCA glue (Glubran II, GEM Italy) as an embolic agent. The treatments required NBCA volumes ranged from 0.1 to 0.6 mL, with different dilutions with ethiodized oil (Lipiodol, Guerbet, France), depending on the entity of the bleeding. Technical success, clinical success, and complications were evaluated. Results: The procedures were successfully concluded in the totality of the patients, achieving full technical and clinical success. In one patient (9.1%), a small upstream of embolic material was encountered, without any consequence. Conclusion: This preliminary experience shows that the use of SeQure is feasible and safe with NBCA.

Fluid-dynamic control microcatheter used with glue: preliminary experience on its feasibility and safety / A.M. Ierardi, E. Stellato, G. Pellegrino, C. Bonelli, M. Cellina, M. Renzulli, P. Biondetti, G. Carrafiello. - In: LA RADIOLOGIA MEDICA. - ISSN 0033-8362. - 127:3(2022), pp. 272-276. [10.1007/s11547-022-01461-0]

Fluid-dynamic control microcatheter used with glue: preliminary experience on its feasibility and safety

E. Stellato;G. Pellegrino;P. Biondetti;G. Carrafiello
Ultimo
2022

Abstract

Purpose: To evaluate feasibility, safety, and success of peripheral embolization procedures carried out using anti-reflux microcatheter with N-butyl-cyanoacrylate (NBCA) as an embolic agent. Methods: We retrospectively described 11 patients that suffered from active bleeding in different body districts, who underwent embolization procedure using SeQure microcatheter (Guerbet, France) with NBCA glue (Glubran II, GEM Italy) as an embolic agent. The treatments required NBCA volumes ranged from 0.1 to 0.6 mL, with different dilutions with ethiodized oil (Lipiodol, Guerbet, France), depending on the entity of the bleeding. Technical success, clinical success, and complications were evaluated. Results: The procedures were successfully concluded in the totality of the patients, achieving full technical and clinical success. In one patient (9.1%), a small upstream of embolic material was encountered, without any consequence. Conclusion: This preliminary experience shows that the use of SeQure is feasible and safe with NBCA.
Anti-reflux microcatheter; Bleeding; Embolic agents; Embolization; NBCA
Settore MEDS-22/A - Diagnostica per immagini e radioterapia
2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
s11547-022-01461-0.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 637.32 kB
Formato Adobe PDF
637.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1167239
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
  • OpenAlex ND
social impact